Literature DB >> 16927522

Viscotoxins, mistletoe lectins and their isoforms in mistletoe (Viscum album L.) extracts Iscador.

Konrad Urech1, Gerhard Schaller, Christoph Jäggy.   

Abstract

The purpose of the following study was to evaluate the presence of the most frequently investigated pharmacologically active mistletoe compounds, viscotoxins (VT) and mistletoe lectins (ML), in European mistletoe Viscum album L. and in the pharmaceutical mistletoe preparations Iscador. Quantitative analysis of the VT isoforms A1, A2, A3, B, 1-PS, and U-PS in fresh mistletoe plant material from the three European subspecies of V. album, during fermentative extraction of mistletoe and in Iscador showed that the pharmaceutical proceeding specific for the preparation of Iscador warrants a high yield of VT. No degradation or transformation of VT during the production process became apparent. The VT compositions of the three host specific European subspecies of V. album, ssp. album, ssp. abietis, and ssp. austriacum, showed characteristic differences. They ensured the identification of the subspecies specific types of Iscador. ML contents of mistletoe extracts were reduced during fermentative extraction. The quantified contents of total ML were 261 +/- 9.3 ng/ml in Iscador M 5 mg spec. and 391 +/- 18.3 ng/ml in Iscador Qu 5 mg spec. Binding of ML to the glycoprotein asialofetuin (type 1) was found to be temperature dependent. Binding activity was increased to 250 % (ML I) and 410 % (ML II and ML III) respectively by decreasing temperature from 30 degrees C to 4 degrees C. 95% of ML could be eliminated from Iscador by affinity chromatography with immobilised glycoproteins at 0 degrees C. Quantitative extraction of ML from the crude extract and their analysis by SDS-PAGE revealed the presence of about 30 % ML I, 20% ML II, and 50% ML III in Iscador M 5 mg spec. and Iscador Qu 5 mg spec. The annual course of concentrations of ML and VT in the leaves of V. album showed maximal ML contents in December and culminaton of VT in June. Seasonal fluctuations of the composition of mistletoe imply the importance of fixed harvesting seasons.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16927522     DOI: 10.1055/s-0031-1296808

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  23 in total

1.  A new development of triterpene acid-containing extracts from Viscum album L. displays synergistic induction of apoptosis in acute lymphoblastic leukaemia.

Authors:  C I Delebinski; S Jaeger; K Kemnitz-Hassanin; G Henze; H N Lode; G J Seifert
Journal:  Cell Prolif       Date:  2012-01-03       Impact factor: 6.831

2.  Viscotoxin and lectin content in foliage and fruit of Viscum album L. on the main host trees of Hyrcanian forests.

Authors:  Sanaz Yousefvand; Farnoosh Fattahi; Seyed Mohsen Hosseini; Konrad Urech; Gerhard Schaller
Journal:  Sci Rep       Date:  2022-06-20       Impact factor: 4.996

3.  Unexpected different binding of mistletoe lectins from plant extracts to immobilized lactose and N-acetylgalactosamine.

Authors:  Tibor Hajtò; Fodor Krisztina; Aponyi Ildikò; Pallai Zsolt; Balogh Pèter; Németh Pèter; Perjési Pàl
Journal:  Anal Chem Insights       Date:  2007-09-17

4.  Viscum album exerts anti-inflammatory effect by selectively inhibiting cytokine-induced expression of cyclooxygenase-2.

Authors:  Pushpa Hegde; Mohan S Maddur; Alain Friboulet; Jagadeesh Bayry; Srini V Kaveri
Journal:  PLoS One       Date:  2011-10-18       Impact factor: 3.240

5.  Interaction of standardized mistletoe (Viscum album) extracts with chemotherapeutic drugs regarding cytostatic and cytotoxic effects in vitro.

Authors:  Ulrike Weissenstein; Matthias Kunz; Konrad Urech; Stephan Baumgartner
Journal:  BMC Complement Altern Med       Date:  2014-01-08       Impact factor: 3.659

6.  Mistletoe: from basic research to clinical outcomes in cancer and other indications.

Authors:  Matthias Kröz; Gunver Sophia Kienle; Gene Feder; Srini Kaveri; Steven Rosenzweig
Journal:  Evid Based Complement Alternat Med       Date:  2014-05-27       Impact factor: 2.629

7.  Mistletoe lectin is not the only cytotoxic component in fermented preparations of Viscum album from white fir (Abies pectinata).

Authors:  Jenny Eggenschwiler; Leopold von Balthazar; Bianca Stritt; Doreen Pruntsch; Mac Ramos; Konrad Urech; Lukas Rist; A Paula Simões-Wüst; Angelika Viviani
Journal:  BMC Complement Altern Med       Date:  2007-05-10       Impact factor: 3.659

8.  Induction of maturation and activation of human dendritic cells: a mechanism underlying the beneficial effect of Viscum album as complimentary therapy in cancer.

Authors:  Sri Ramulu Elluru; Jean-Paul Duong van Huyen; Sandrine Delignat; Michel D Kazatchkine; Alain Friboulet; Srini V Kaveri; Jagadeesh Bayry
Journal:  BMC Cancer       Date:  2008-06-04       Impact factor: 4.430

9.  A Natural Combination Extract of Viscum album L. Containing Both Triterpene Acids and Lectins Is Highly Effective against AML In Vivo.

Authors:  Catharina I Delebinski; Monika Twardziok; Susann Kleinsimon; Florian Hoff; Katharina Mulsow; Jana Rolff; Sebastian Jäger; Angelika Eggert; Georg Seifert
Journal:  PLoS One       Date:  2015-08-05       Impact factor: 3.240

10.  Evaluation of Preclinical Assays to Investigate an Anthroposophic Pharmaceutical Process Applied to Mistletoe (Viscum album L.) Extracts.

Authors:  Stephan Baumgartner; Heidi Flückiger; Matthias Kunz; Claudia Scherr; Konrad Urech
Journal:  Evid Based Complement Alternat Med       Date:  2014-05-04       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.